Skip to content
GenoLensGenoLens

DNASE2

Chr 19p13.13

deoxyribonuclease 2, lysosomal

MANE:
ENST00000222219.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • COVID-19 research

    BIALLELIC, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency

    0.69
  • systemic lupus erythematosus

    0.11
  • arthropathy

    0.08
  • obesity disorder

    0.07
  • breast cancer

    0.06
  • breast carcinoma

    0.06
  • Hemoglobin C - beta-thalassemia

    0.05
  • hemoglobin C-beta-thalassemia syndrome

    0.05
  • type 2 diabetes mellitus

    0.05
  • hemoglobin D disease

    0.05

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Deoxyribonuclease-2-alpha

Hydrolyzes DNA under acidic conditions with a preference for double-stranded DNA. Plays a major role in the clearance of nucleic acids generated through apoptosis, hence preventing autoinflammation (PubMed:29259162, PubMed:31775019). Necessary for proper fetal development and for definitive erythropoiesis in fetal liver and bone marrow, where it degrades nuclear DNA expelled from erythroid precursor cells (PubMed:29259162)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.